Artigo de periodico

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population (2023)

• Authors:
  • Farias, Jéssica Pires
  • Andreata-Santos, Robert
  • Brito, Ruth Dalety da Silva
  • Souza, Milena Silva
  • Fogaça, Mayanna Moreira Costa
  • Pinheiro, Josilene Ramos
  • Cruz, Edgar Ferreira da
  • Liang, Willian
  • Simões, Rafael da Conceição
  • Luiz, Wilson Barros
  • Birbrair, Alexander
  • Vidal, Paloma Oliveira
  • Maricato, Juliana Terzi
  • Braconi, Carla Torres
  • Janini, Luiz Mário Ramos
  • Amorim, Jaime Henrique
  • Ferreira, Luis Carlos de Souza
• Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
• Unidade: ICB
• DOI: 10.1128/spectrum.02857-23
• Subjects: MICROBIOLOGIA; COVID-19; EPITOPOS; VARIAÇÃO GENÉTICA; VACINAS VIRAIS; ANTICORPOS; GENOMAS; SEQUENCIAMENTO GENÉTICO; ESTUDOS RETROSPECTIVOS
• Agências de fomento:
  • Financiamento CAPES
  • Financiamento CNPq
  • Financiamento FAPESB
  • Financiamento (FINEP)
  • Financiamento FAPESP
• Language: Inglês
• Imprenta:
  • Publisher: American Society for Microbiology
  • Publisher place: Washington, DC
  • Date published: 2023
• Source:
  • Título: Microbiology Spectrum
  • ISSN: 2165-0497
  • Volume/Número/Paginação/Ano: v. 11, n. 6, art. e02857-23, 16 p., 2023


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo publicado em periódico de acesso aberto (Gold Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• URL de acesso aberto
• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	The fourth COVID-19 vacci...	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  FARIAS, Jéssica Pires et al. The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population. Microbiology Spectrum, v. 11, n. 6, p. 16 , 2023Tradução . . Disponível em: https://doi.org/10.1128/spectrum.02857-23. Acesso em: 27 mar. 2026.

• APA

  Farias, J. P., Andreata-Santos, R., Brito, R. D. da S., Souza, M. S., Fogaça, M. M. C., Pinheiro, J. R., et al. (2023). The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population. Microbiology Spectrum, 11( 6), 16 . doi:10.1128/spectrum.02857-23

• NLM

  Farias JP, Andreata-Santos R, Brito RD da S, Souza MS, Fogaça MMC, Pinheiro JR, Cruz EF da, Liang W, Simões R da C, Luiz WB, Birbrair A, Vidal PO, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S. The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population [Internet]. Microbiology Spectrum. 2023 ; 11( 6): 16 .[citado 2026 mar. 27 ] Available from: https://doi.org/10.1128/spectrum.02857-23

• Vancouver

  Farias JP, Andreata-Santos R, Brito RD da S, Souza MS, Fogaça MMC, Pinheiro JR, Cruz EF da, Liang W, Simões R da C, Luiz WB, Birbrair A, Vidal PO, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S. The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population [Internet]. Microbiology Spectrum. 2023 ; 11( 6): 16 .[citado 2026 mar. 27 ] Available from: https://doi.org/10.1128/spectrum.02857-23

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Evaluation of experimental conditions for quantification of LT produced by human derived enterotoxigenic Escherichia coli strains
• New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains based on intimin expression by recombinant Bacillus subtilis strains
• New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains
• Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules
• Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action
• Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells
• Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors
• Bivalent DNA vaccines confer prophylactic and therapeutic effect on HPV-16 murine tumor
• Expression of a treptococcal M protein epitope fused at different sites of flagellin (FliCd) as an approach for the development of bivalent vaccines based on attenuated Salmonella strains
• Evaluation of the prophylactic and therapeutic effects of anti-cancer DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the HSV-1 GD